Literature DB >> 32018266

Brief Report: A Case of Tramadol Overdose: Extracorporeal Life Support and Hemoperfusion as Life-Saving Treatment.

Fiorenza Ferrari1,2, Alessandro Carletti3, Nicola Peroni3, Silvia Mongodi3, Pasquale Esposito4,5, Anita Orlando3, Francesco Mojoli3,6, Claudio Ronco7,8,9, Mirko Belliato3, Giorgio A Iotti3.   

Abstract

We describe the case of a 49-year-old woman with a Tramadol intoxication associated with multiorgan failure. Veno-arterial femoro-femoral extracorporeal life support (VA-ECLS) and hemoperfusion (HP) were used as rescue treatments. The emergency medical service found a woman at home unconscious. Once in the hospital, she was intubated and catecholamines support was immediately started for a severe shock. Brain CT was normal, whereas EEG revealed a metabolic encephalopathy pattern. Toxic levels of Tramadol and Quetiapine were detected. VA-ECLS was implanted due to persistent multiorgan failure, and HP with a charcoal cartridge was set to increase the Tramadol clearance. To quantify the charcoal cartridge's removal efficiency of Tramadol, Tramadol concentration was measured before and after the cartridge and before and after the treatment in the patient's blood. The charcoal cartridge showed good extraction ratio during the treatment and no significant rebound effect. VA-ECLS and HP allowed the patient to be weaned from vasoconstrictors and the resolution of the organ failures. These treatments might be lifesaving in the Tramadol intoxication.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Blood purification; Continuous renal replacement therapy; Extracorporeal life support; Hemoperfusion; Intoxication; Refractory shock

Mesh:

Substances:

Year:  2020        PMID: 32018266     DOI: 10.1159/000505845

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  1 in total

Review 1.  Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.

Authors:  Erin L Winstanley; James J Mahoney; Felipe Castillo; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.